Renewing the Fight Against Bacteria

In the 1940s, the mass production of penicillin led to a sensational reduction in illness and death from bacterial disease. A resulting golden era of bacterial research emerged with new classes of antibiotics, and by 1969, US Surgeon General William H. Stewart told Congress: "The time has come to close the book on infectious disease." As a result, fewer new students specialized in bacterial physiology, and federal funders shifted their focus to more immediately pressing diseases, as did many pha

Written byJennifer Fisher Wilson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

As a result, fewer new students specialized in bacterial physiology, and federal funders shifted their focus to more immediately pressing diseases, as did many pharmaceutical companies. But while everyone forgot about the bacteria, the bacteria didn't completely abandon their unwilling hosts.

Today, nearly all strains of Staphylococcus aureus, an organism that causes skin, bone, lung, and bloodstream infections, now resist penicillin. Many do the same to methicillin, and some even resist vancomycin, long considered the only uniformly effective drug for methicillin-resistant S. aureus, according to the Centers for Diseases Control and Prevention (CDC). The agency also estimates that 30% of Streptococcus pneumoniae-caused pneumonia, meningitis, and ear infections no longer respond to penicillin. In fact, about 70% of bacteria found in hospitals resist at least one of the drugs most commonly used to treat infection, according to CDC estimates. Antibiotics resistance continues to increase; much of it occurs from misuse. Physicians ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH